Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node

Modern Pathology

Volumn 17, Issue 7, 2004, Pages 747-755

  Cochran, Alistair J ^a,b   Wen, Duan Ren ^a   Huang, Rong Rong ^a   Wang, Hei Jing ^c   Elashoff, Robert ^c   Morton, Donald L ^d  

^a Dept of Pathol and Lab Medicine ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Immune suppression; Melanoma; Melanoma death; Sentinel node; Tumor burden; Tumor recurrence

Indexed keywords

ACCURACY; ARTICLE; BODY BURDEN; BRESLOW THICKNESS; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CELL DENSITY; DENDRITIC CELL; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MELANOMA; METASTATIC MELANOMA; NONSENTINEL LYMPH NODE; PREDICTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR RECURRENCE; TUMOR VOLUME;

HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 3042667896     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800117     Document Type: Article

References (34)

1. Cochran AJ, Morton DL, Stern S, et al. Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: Implications for tumor biology and treatment. Mod Pathol 2001;14:604-608.
2. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
3. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Arch Surg 1994;220:391-398.
4. Saha S, Nora D, Wong JH, et al. Sentinel lymph node mapping in colorectal cancer - a review. Surg Clin North Am 2000;80:1811-1819.
5. Wong JH, Steineman S, Calderia C, et al. Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg 2001;233:515-521.
6. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.
7. Ghurani GB, Penalver MA. An update on vulvar cancer. Am J Obstet Gynecol 2001;185:294-299 (Review).
8. Cochran AJ, Roberts AA, Saida T. The place of lymphatic mapping and sentinel node biopsy in oncology. Int J Clin Oncol 2003;8:139-150.
9. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early stage melanoma: a multicenter trial. Ann Surg 1999;230:453-455.
10. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902-908.
11. Cochran AJ, Lana AMA, Wen D-R. Histomorphometry in the assessment of prognosis in Stage II melanoma. Am J Surg Pathol 1989;13:600-604.
12. Cochran AJ, Pihl E, Wen D-R, et al. Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies. J Natl Cancer Inst 1987;78:399-405.
13. Huang RR, Wen D-R, Guo J, et al. Modulation of paracortical dendritic cells and T lymphocytes in breast cancer sentinel nodes. Breast J 2000;6:225-232.
14. Lana A-MA, Wen D-R, Cochran AJ. The morphology, immunophenotype and distribution of paracortical dendritic leukocytes in lymph nodes regional to cutaneous melanoma. Melanoma Res 2001;11:1-10.
15. Cochran AJ. Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes. Am J Surg Pathol 1999;23:1169-1172.
16. Messina JL, Reintgen DS, Cruse CW, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997;4:389-395.
17. Cochran AJ. sentinel lymph node biopsy for melanoma: pathologic aspects. In: H.S.C. III (ed). Sentinel Lymph Node Biopsy. Martin Duntz: New York, 2002, pp. 79-90.
18. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-399 (discussion 399-01, review).
19. Cochran AJ, Morton DL, Johnson TD, et al. Prediction of outcome and tumor status of the non-sentinel node in melanoma patients with a positive sentinel node. Mod Pathol 2001;13:61A.
20. Wen D-R, Huang R-R, Starz H, et al. Prognostic factors predict nonsentinel node status in melanoma patients. Mod Pathol 2003;16:101A.
21. Joseph E, Brobeil A, Glass F, et al. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol 1998;5:119-125.
22. Clary BM, Brady MS, Lewis JJ, et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 2001;233:250-258.
23. Haddad FF, Stall A, Messina J, et al. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol 1999;6:144-149.
24. Reeves ME, Delgado R, Busam KJ, et al. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol 2003;10:27-31.
25. Wagner JD, Gordon MS, Chuang TY, et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 2000;89:453-462.
26. Wagner JD, Park HM, Coleman III JJ, et al. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax. Arch Otolaryngol Head Neck Surg 2000;126:313-321.
27. McMasters KM, Wong SL, Edwards MJ, et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2002;2:137-141.
28. Carlson GW, Murray DR, Lyles RH, et al. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 2003;10:575-581.
29. Cochran AJ, Binder S, Remotti F. The role of microscopic evaluation in the management of cutaneous melanoma. Cancer Treat Res 1993;65:69-102.
30. Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001;91:2110-2121.
31. Düker I, Starz H, Bachter D, et al. Prognostic and therapeutic implications of sentinel lymphonodectomy and S-staging in Merkel cell carcinoma. Dermatology 2001;202:225-229.
32. Wagner JD, Davidson D, Coleman III JJ, et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol 1999;6:398-404.
33. Ranieri JM, Wagner JD, Azuaje R, et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol 2002;9:975-981.
34. Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001;92:1378-1384.